The presence of more aggressive tumor features, including a high tumor grade, triple-negative tumors, and Ki67 ≥ 25%, may explain why YW with BRCA mutation showed a worse clinical prognosis in terms of recurrence and survival compared with non-carriers; however, previous studies reported conflicting results. Here, MKI67 is linked to neoplasm.